CDK4 and breast carcinoma: Cyclin D–CDK4/6 complexes are hyperactivated and drive uncontrolled tumor proliferation in many cancer types and many preclinical studies demonstrated that, while they are relevant for the growth of many tumor types, they often become essential in breast cancer (BC) (26, 28, 71, 72).